Author

Randall S. MacGill

Program for Appropriate Technology in HealthORCID 0000-0002-4566-1481Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:plant (other)· 1 Organism:rat· 1

Frequent Co-Authors

C. Richter KingiD· 2 shared Cassandra A. RigbyiD· 2 shared Doris QuinkertiD· 2 shared Jordan R. BarrettiD· 2 shared Kirsty McHughiD· 2 shared Simon J. DraperiD· 2 shared Alexander D. DouglasiD· 1 shared Allison SeegeriD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Richter KingORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintJun 8, 2026

Structure and functional diversity of antibodies targeting the P. falciparum circumsporozoite protein C-terminal domain

Re’em Moskovitz, Iszac Burton, Nathan Beutler…·Ian A. Wilson

This study characterizes the structure and function of antibodies targeting the conserved β-epitope region of PfCSP, showing how they achieve strain-transcending recognition and enhance Fc-mediated immune responses.

DOI 10.64898/2026.06.06.730512

plant (other)experimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 26, 2025

Synergistic non-neutralizing plasma antibodies to PfRH5 drive potent malaria parasite growth inhibition

Jeffrey Marchioni, Kirsty McHugh, Jordan R. Barrett…·Jason J. Lavinder

The paper identifies synergistic non-neutralizing antibodies against PfRH5 that enhance malaria parasite growth inhibition when combined with neutralizing antibodies.

DOI 10.64898/2025.12.24.696081

humanproteomics

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedJun 7, 2024

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Barnabas G. Williams, Lloyd D. W. King, David Pulido…·Simon J. Draper

This paper develops a combination malaria vaccine targeting the RCR-complex by fusing epitopes from RIPR to CyRPA, improving in vitro growth inhibition compared to RH5.1 alone.

34 citationstop 1%

ratproteomics

𝕏 PostBluesky